Hand of healthcare professional mid-procedure

Reference & Resources of Interest

Featured Article

Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events (MADIT-CRT)

Arthur J. Moss, M.D., W. Jackson Hall, Ph.D., David S. Cannom, M.D., Helmut Klein, M.D., Mary W. Brown, M.S., James P. Daubert, M.D., N.A. Mark Estes, III, M.D., Elyse Foster, M.D., Henry Greenberg, M.D., Steven L. Higgins, M.D., Marc A. Pfeffer, M.D., Ph.D., Scott D. Solomon, M.D., David Wilber, M.D., Wojciech Zareba, M.D., Ph.D., for the MADIT-CRT Trial Investigators

** The use of a CRT-D in asymptomatic or mildly symptomatic patients (Class I or II) with reduced ejection fraction and a wide QRS complex as outlined in the attached publication in the MADIT-CRT study, has not been approved for use or cleared by the FDA.**

| September 1, 2009

Featured Video

A Review of 7F ICD Lead Performance

James Porterfield, MD, FACC, Methodist University Hospital, Memphis, TN; Raffaele Corbisiero, MD, Deborah Heart and Lung Institute, Browns Mills, NJ | December 7, 2009

Green Arrow  Access Video
Please note, you will be prompted to register prior to accessing the video for the first time. 

This video presents a brief discussion with two of the main authors of the largest multicenter retrospective study recently published on the clinical performance of the St. Jude Medical ICD lead. In their evaluation, Drs. Porterfield and Corbisiero have demonstrated that the incidence of lead adverse events in the Riata™ family of ICD leads was considerably rare (less than 1% for each type of adverse event) and within the range of what is considered clinically acceptable.

Length:         10:46

Recorded:    December 7, 2009  

The opinions presented here are those of the physicians and do not necessarily reflect those of St. Jude Medical.

Featured Video

Advanced ICD Lead Connection  

Advanced ICD Lead Connection

Raffaele Corbisiero, M.D. Chair, Department of Electrophysiology Deborah Heart and Lung Center | May 13, 2009

Dr. Corbisiero presents at the Heart Rhythm Society 2009 on the new connector system. His discussion covers why the new connector was developed, looks at the existing and new SJ4 ICD lead design and their differences. Current and post approval studies are also covered by Dr. Corbisiero.

Length: 09:31

 

The opinions presented here are those of the physician and do not necessarily reflect those of St. Jude Medical.

Featured Presentation

The St. Jude Medical Biocor Bioprosthesis: Clinical Evidence of Long-term Durability

St. Jude Medical | October 13, 2009

Twenty-five years of clinical experience. Two decades of in-depth research. Two recently published peer-reviewed studies. This presentation includes a review and comparative assessment of the proven 20-year long-term durability of the Biocor Tissue Valve.